http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#Head http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#assertion http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#provenance http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#pubinfo http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#assertion http://purl.obolibrary.org/obo/DOID_11247 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_11247 http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00513 http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association http://www.w3.org/2000/01/rdf-schema#label "Aminocaproic Acid Tablets should not be used when there is evidence of an active intravascular clotting process. When there is uncertainty as to whether the cause of bleeding is primary fibrinolysis or disseminated intravascular coagulation (DIC), this distinction must be made before administering Aminocaproic Acid Tablets. The following tests can be applied to differentiate the two conditions: Platelet count is usually decreased in DIC but normal in primary fibrinolysis. Protamine paracoagulation test is positive in DIC; a precipitate forms when protamine sulfate is dropped into citrated plasma. The test is negative in the presence of primary fibrinolysis. The euglobulin clot lysis test is abnormal in primary fibrinolysis but normal in DIC. Aminocaproic Acid Tablets must not be used in the presence of DIC without concomitant heparin." http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB00513 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#provenance http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#pubinfo http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#sig http://purl.org/nanopub/x/hasSignature ODGe7vGaGc3W9mi7TbXoKvYpzKS+Q8bRiCrpuCcamMOWqrv2gQLU31foEEtADxjwpfIJD/IKQHDirJGCrdt8xvx5T7tttGxX/TQ7Q+/gR02KH3maeJx1c9jyUXiRmal0gKWZAO5qkgGRBCvHHeofsrbWGHzioIxTmOlJhIovz5Q= http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g http://purl.org/dc/terms/created 2021-08-25T13:40:12.079+02:00 http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAqKqgVQzBmXHOFCWNesw4WDw5xvGFvUAyzD5DjBgdM7g https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY